Mojca Jongen‐Lavrencic

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Bob Löwenberg, Gert J. Ossenkoppele, Wim van Putten et al. · New England Journal of Medicine · 2009 · 818 citations · Full text

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

Mojca Jongen‐Lavrencic, Tim Grob, Diana Hanekamp et al. · New England Journal of Medicine · 2018 · 756 citations · Full text

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

Mojca Jongen‐Lavrencic, Su Ming Sun, M K Dijkstra et al. · Blood · 2008 · 407 citations · Full text

The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation

Su Jung Song, Keisuke Ito, Ugo Ala et al. · Cell stem cell · 2013 · 319 citations · Full text

Tet2 Tumor Suppressor, Medicine, Stem Cell Research +9

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 307 citations · Full text